NOT KNOWN FACTS ABOUT MOUNJARO TIRZEPATIDE 12.5MG INJECTIONS

The trial accomplished each its Major endpoints, with semaglutide 2.4 mg demonstrating statistically considerable and exceptional improvements in liver fibrosis with no worsening of steatohepatitis, together with resolution of steatohepatitis with no worsening of liver fibrosis in individuals with MASH as compared to placebo.1Your Mounjaro pen migh